Single-cell dissection of CD4 T cell changes in patients with immune-related adverse events following PD-1 inhibition
PD-1 抑制后出现免疫相关不良事件的患者 CD4 T 细胞变化的单细胞解剖
基本信息
- 批准号:10571532
- 负责人:
- 金额:$ 17.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-01 至 2027-12-31
- 项目状态:未结题
- 来源:
- 关键词:AffectAntigensAutoimmuneAutoimmune DiseasesAutoimmunityBioinformaticsBloodCD28 geneCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCaringCellsClinicalClinical ResearchClonal ExpansionClonalityCollaborationsCommunicationDataDevelopmentDevelopment PlansDissectionEarly DiagnosisEarly InterventionEarly treatmentEpigenetic ProcessEvaluationEventExhibitsFacultyFeedbackFoundationsFunctional disorderFundingGene Expression ProfileGenetic TranscriptionGoalsGrantGrowthHelper-Inducer T-LymphocyteHomeostasisHumanImmuneImmunizationImmunotherapyImpairmentInflammatoryInfluenza vaccinationInterventionMalignant NeoplasmsMediatingMedicalMemoryMentorsMolecular TargetOncology GroupPD-1 pathwayPathologyPathway interactionsPatientsPennsylvaniaPhasePhysiciansPopulationPositioning AttributePreparationPreventionProductivityProxyResearchResearch PersonnelResolutionRheumatismRheumatologySamplingScientistShapesSignal TransductionSurfaceT cell responseT-LymphocyteTestingTimeToxic effectTrainingTranscriptional RegulationTranslational ResearchUnited States National Institutes of HealthUniversitiesVaccinationVaccinesWritinganalytical toolanti-PD-1anti-PD1 therapyautoimmune toxicityautoreactivitycancer immunotherapeuticscancer therapycareercareer developmentcellular targetingcheckpoint inhibitioncohortcollaborative environmentdesignepigenetic regulationexperiencefitnessimmune-related adverse eventsimmunopathologyinfluenza virus vaccinemultimodalitynovelnovel strategiespermissivenesspre-clinicalpreventprogrammed cell death protein 1programsprospectiverecruitresponseseasonal influenzasingle cell analysissingle cell technologyskillssystemic autoimmune diseasetenure tracktumor
项目摘要
Project Summary
This application proposes a five-year research and training plan with a scientific focus on the mechanisms
through which PD-1 checkpoint inhibition leads to immune-related adverse events (irAEs). The hypothesis is
that de novo loss of PD-1 signaling enhances the antigen sensitivity of CD4 T cells and leads to the activation of
autoreactive CD4 T cells that mediate irAE development. To investigate this hypothesis, the candidate will
analyze two complementary human cohorts of his mentors: a) a prospective irAE cohort of patients on PD-1
immunotherapy to compare the early changes of CD4 T cells in patients who do (irAE+) and do not (irAE-) develop
irAEs, and b) a cohort of patients on PD-1 immunotherapy that receive seasonal influenza vaccination to test
whether any underlying immunopathology in irAE+ patients, not otherwise observed with evaluation of basal
states, can be revealed with the help of immunization. Using the prospective irAE cohort, Aim 1 will evaluate
whether patients that develop irAEs have a different naïve CD4 T cell epigenetic and transcriptional profile at
baseline that allows robust activation of autoreactive CD4 T cells following PD-1 inhibition. Further, this aim will
analyze the transcriptional profile and clonal diversity of the activated CD4 T cells generated after PD-1 inhibition
in irAE+ patients. Using the aPD-1 cohort of influenza vaccination, Aim 2 will answer the question of whether
PD-1 signaling is required to finetune the TCR threshold and transcriptional profile of CD4 T cell responses to
maintain immune fitness and homeostasis. These studies will define the path through which PD-1 inhibition leads
to the activation and propagation of autoreactive CD4 T cells to cause immune-mediated pathology. They will
also identify cellular and molecular targets that can be used for early diagnosis and treatment of patients with
rheumatologic and other irAEs. Scientifically, the candidate’s career development goals are to gain expertise
in the conduct of clinical and translational research, bioinformatic analyses, single-cell technologies, and
transcriptional and epigenetic regulation of autoimmune pathways in patient samples. Professionally, the
candidate aims to gain experience in scientific writing, grant preparation, communication, and data presentation
culminating to an R01 submission. To facilitate the candidate’s growth as a physician-scientist, this proposal
combines novel experimental single-cell approaches and a specific career development plan designed by the
candidate and his mentors, Dr. Wherry and Dr. Laufer. The candidate’s long-term goal is to transition to a tenure-
track faculty position and to develop an independent NIH-funded research program focusing on the mechanisms
of autoimmunity and T cell dysfunction to ultimately prevent and treat rheumatologic diseases. The rich scientific
and collaborative environment at the University of Pennsylvania will position the candidate to have a highly
impactful, translational research career in human autoimmunity.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sokratis Apostolidis其他文献
Sokratis Apostolidis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Discovery of autoimmune antigens from non-coding sequences
从非编码序列发现自身免疫抗原
- 批准号:
10286063 - 财政年份:2021
- 资助金额:
$ 17.33万 - 项目类别:
Discovery of autoimmune antigens from non-coding sequences
从非编码序列发现自身免疫抗原
- 批准号:
10450060 - 财政年份:2021
- 资助金额:
$ 17.33万 - 项目类别:
A Multiomic Search for Antigens in Autoimmune Hepatitis
自身免疫性肝炎抗原的多组学研究
- 批准号:
10263272 - 财政年份:2020
- 资助金额:
$ 17.33万 - 项目类别:
Autoimmune Regulator gene (Aire)-mediated tolerance to pregnancy-associated self-antigens
自身免疫调节基因(Aire)介导的对妊娠相关自身抗原的耐受性
- 批准号:
10219063 - 财政年份:2019
- 资助金额:
$ 17.33万 - 项目类别:
Autoimmune Regulator gene (Aire)-mediated tolerance to pregnancy-associated self-antigens
自身免疫调节基因(Aire)介导的对妊娠相关自身抗原的耐受性
- 批准号:
10455466 - 财政年份:2019
- 资助金额:
$ 17.33万 - 项目类别:
Autoimmune Regulator gene (Aire)-mediated tolerance to pregnancy-associated self-antigens
自身免疫调节基因(Aire)介导的对妊娠相关自身抗原的耐受性
- 批准号:
10684826 - 财政年份:2019
- 资助金额:
$ 17.33万 - 项目类别:
Study of novel antigens and their pathogenic roles of autoimmune neurological disorders including Guillain-Barre syndrome.
研究新抗原及其对包括格林-巴利综合征在内的自身免疫性神经系统疾病的致病作用。
- 批准号:
18K07403 - 财政年份:2018
- 资助金额:
$ 17.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Attempt at identifying pathogenic antigens of painful autoimmune neuropathy
尝试鉴定疼痛性自身免疫性神经病的致病抗原
- 批准号:
16K15339 - 财政年份:2016
- 资助金额:
$ 17.33万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
analysis of newly target auto antigens in autoimmune encephalitis
自身免疫性脑炎新靶标自身抗原分析
- 批准号:
25461286 - 财政年份:2013
- 资助金额:
$ 17.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of tolerance mechanism against peripheral target antigens in autoimmune diseases
阐明自身免疫性疾病中针对外周靶抗原的耐受机制
- 批准号:
17109012 - 财政年份:2005
- 资助金额:
$ 17.33万 - 项目类别:
Grant-in-Aid for Scientific Research (S)